Schrödinger is launching the AI agent system Bunsen to use its physics-based drug design software. CEO Ramy Farid calls it 'transformative.'
Ramy Farid, Schrödinger CEO
July 27, 2026 07:00 AM EDT
Exclusive: Schrödinger CEO 'couldn't be more pleased to be wrong' in launch of AI agent Bunsen
Andrew Dunn
Senior Biopharma Correspondent
The AI drug boom has a long way to go before reaching patients.
On Tuesday, Anthropic announced Claude Science, a new product that company leaders describe as an AI workbench for scientific…
The pursuit to develop the most powerful artificial intelligence engine is on even as the risks and rewards of the new technology…
Red-hot generative AI specialist Insilico Medicine has teamed up with another major biopharma player, this time linking up with…
Also: All the news and watercooler chat from Fortune.
Inceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The Readout
